- Entry
- $0.86
- Now
- $4.16 +384.0%
- Target
- —
- Score
- —
Enlivex Ltd. (ENLV) is Nasdaq listed biotech that has quite promising drug in phase 2. But contrary to the usual biotech firm this is actually not the most important thing about the company at this junction. Reason is there's quite unique opportunity available due to their crypto treasury strategy where some time ago they invested a lot of money to crypto token called RAIN. Since then the Rain protocol has gained a lot of interest and based on today's market …
— ORIGINAL POST ·
ENLV has $16 per share worth of RAIN tokens in the balance sheet and SP is at $0.85
· r/stocks
· Jun 2, 2026